Jefferson Bridge Capital LLC Purchases Shares of 9,265 HCA Healthcare, Inc. $HCA

Jefferson Bridge Capital LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 9,265 shares of the company’s stock, valued at approximately $4,325,000. HCA Healthcare comprises about 4.4% of Jefferson Bridge Capital LLC’s portfolio, making the stock its 5th biggest holding.

A number of other institutional investors have also bought and sold shares of the company. MBL Wealth LLC boosted its position in HCA Healthcare by 12.6% during the fourth quarter. MBL Wealth LLC now owns 3,256 shares of the company’s stock valued at $1,520,000 after acquiring an additional 365 shares during the last quarter. Aaron Wealth Advisors LLC boosted its position in shares of HCA Healthcare by 34.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 3,529 shares of the company’s stock worth $1,648,000 after purchasing an additional 900 shares in the last quarter. Sound Income Strategies LLC boosted its position in shares of HCA Healthcare by 8.7% during the 4th quarter. Sound Income Strategies LLC now owns 460 shares of the company’s stock worth $216,000 after purchasing an additional 37 shares in the last quarter. Sowell Financial Services LLC boosted its position in shares of HCA Healthcare by 171.1% during the 4th quarter. Sowell Financial Services LLC now owns 3,975 shares of the company’s stock worth $1,856,000 after purchasing an additional 2,509 shares in the last quarter. Finally, Savvy Advisors Inc. boosted its position in shares of HCA Healthcare by 35.3% during the 4th quarter. Savvy Advisors Inc. now owns 840 shares of the company’s stock worth $392,000 after purchasing an additional 219 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $488.74 on Wednesday. The firm has a market cap of $109.27 billion, a price-to-earnings ratio of 17.22, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $314.43 and a 52 week high of $556.52. The firm has a 50-day moving average price of $511.03 and a two-hundred day moving average price of $480.20.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were paid a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date was Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.99%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on HCA shares. Jefferies Financial Group increased their price objective on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Royal Bank Of Canada increased their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Friday, March 27th. JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research report on Friday, February 20th. Finally, The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.